Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new actonel clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on actonel
- Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis
Status: Recruiting, Condition Summary: Glucocorticoid Induced Osteoporosis - Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
Status: Recruiting, Condition Summary: Postmenopausal Osteoporosis; Back Pain; Spinal Fracture - A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Status: Active, not recruiting, Condition Summary: Post-Menopausal Osteoporosis - Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects
Status: Completed, Condition Summary: Osteoporosis - SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.
Status: Recruiting, Condition Summary: Colles' Fracture - Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Status: Active, not recruiting, Condition Summary: Osteoporosis - Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Status: Active, not recruiting, Condition Summary: Postmenopausal Osteoporosis - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
Status: Recruiting, Condition Summary: Bone Loss; Osteoporosis; Breast Cancer - ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
Status: Terminated, Condition Summary: Osteoporosis - Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Osteoporosis; Prostate Cancer - Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Status: Active, not recruiting, Condition Summary: Breast Cancer; Osteoporosis - Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
Status: Recruiting, Condition Summary: Breast Cancer; Osteoporosis - Risedronate in Osteopenic Postmenopausal Women
Status: Active, not recruiting, Condition Summary: Osteoporosis - A Study of Monthly Risedronate for Osteoporosis
Status: Completed, Condition Summary: Postmenopausal Osteoporosis - A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
Status: Active, not recruiting, Condition Summary: Postmenopausal Osteoporosis - Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Status: Recruiting, Condition Summary: Post-Menopausal Osteoporosis - POWER Point of Care Effect on Satisfaction of Treatment
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - A Study to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - Risedronate Sodium in Post Menopausal Osteoporosis
Status: Completed, Condition Summary: Osteoporosis, Postmenopausal - Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
Status: Completed, Condition Summary: Postmenopausal Osteoporosis - Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy
Status: Completed, Condition Summary: Osteoporosis - Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
Status: Active, not recruiting, Condition Summary: Osteogenesis Imperfecta - Pharmacokinetics of a Single 14C-Labeled Dose of Risedronate or Alendronate Followed by Once-a-Week Unlabeled Oral Dose
Status: Completed, Condition Summary: Osteopenia; Osteoporosis - Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Status: Completed, Condition Summary: Male Osteoporosis - Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
Status: Completed, Condition Summary: Postmenopausal Women